March 13, 2020
March 13, 2020
Due to unforeseen circumstances surrounding the new coronavirus (COVID-19), the 2020 Advocacy Workshop: Genetics, Genomics and Biomarker Testing is rescheduled for September 9, 2020. Though the date has changed, the location will remain the FHI 360 Conference Center at 1825 Connecticut Ave NW, 8th Floor, Washington, D.C. 20009.
The Prevent Cancer Foundation® is committed to the health and well-being of all populations. Our shared advocacy work is important to us, but now is the time to work together to reduce the risk of exposure and ensure all our communities are safe.
We sincerely apologize for any inconvenience this may cause and look forward to greeting you and your colleagues on September 9, 2020.
For any questions or concerns, please contact: Taylor Patton at firstname.lastname@example.org or (703) 519-2216.
March 2020 marks the 20th anniversary of Colorectal Cancer Awareness Month! It’s a great time to get a refresher on what you can do to reduce your risk.
Here are some ideas on how to get involved:
With your help, we can create awareness and make this the most successful Colorectal Cancer Awareness Month yet!
The One Voice Against Cancer (OVAC) coalition, a group of cancer-related patient advocacy organizations and provider groups, submitted its appropriations requests, seeking funding for various health care agencies supporting cancer screenings, treatment and research.
The requests are as follows:
The full breakdown of supported programs can be found here.
As a member of OVAC, the Prevent Cancer Foundation® stands with our fellow advocacy organizations in seeking appropriate funding to ensure federal agencies have the resources they need to continue their critical work improving cancer care. Together, we can Stop Cancer Before It Starts!®
In an op-ed to The Wall Street Journal this week, White House Domestic Policy Council Director Joe Grogan presented the principles guiding the Trump administration’s approach to drug pricing efforts.
In the piece, he highlighted five goals:
“These White House principles for drug-pricing legislation are achievable. They have been endorsed by members of Congress from both sides of the aisle,” Grogan said.
Though reducing drug pricing has long been a goal for both Democrats and Republicans, Congress has yet to agree on how to achieve these cost reductions. Proposals from both the House and Senate have been introduced, but neither has been able to pull in the bipartisan support to push them through the legislative process. In the 2020 election year, health care continues to be a priority for voters across the country. Many actions and proposals are likely to be presented over the course of the next year, and we will provide updates as they develop.